Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H16N4NaO8S |
InChIKeyBAJSKIYRJKPEIM-JTBFTWTJSA-N |
CAS Registry56238-63-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | Phase 3 | China | 20 Jan 2014 | |
| Acute Bronchitis | Phase 1 | - | 09 Oct 2013 | |
| Adenotonsillitis | Phase 1 | - | 09 Oct 2013 | |
| Arthritis, Infectious | Phase 1 | - | 09 Oct 2013 | |
| Bacteriuria | Phase 1 | - | 09 Oct 2013 | |
| Bone and joint infections | Phase 1 | - | 09 Oct 2013 | |
| Bronchiectasis | Phase 1 | - | 09 Oct 2013 | |
| Bronchitis, Chronic | Phase 1 | - | 09 Oct 2013 | |
| Cellulitis | Phase 1 | - | 09 Oct 2013 | |
| Cystitis | Phase 1 | - | 09 Oct 2013 |





